Impact of Genetic Variants on the Toxicity of Antibody-Drug Conjugates in Locally Advanced or Metastatic Breast Cancer: The Role of the UGT1A1 Gene as a Predictive Biomarker of Therapeutic Response

Name: Impact of Genetic Variants on the Toxicity of Antibody-Drug Conjugates in Locally Advanced or Metastatic Breast Cancer: The Role of the UGT1A1 Gene as a Predictive Biomarker of Therapeutic Response
Published: 2025
License: Public Domain

Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental · 2025

ClinicalTrials.gov · Datasets · License: Public Domain · 2025

Open Source ↗

breast-cancer polymorphism toxicity

breast cancer, metastatic breast cancer, drug-related side effects and adverse reactions, pharmacogenetic variant, ugt1a1, genetic variants, toxicity, polymorphism, sacituzumab govitecan, trastuzumab deruxtecan, datopotamab deruxtecan, observational

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Impact of Genetic Variants on the Toxicity of Antibody-Drug Conjugates in Locally Advanced or Metastatic Breast Cancer: The Role of the UGT1A1 Gene as a Predictive Biomarker of Therapeutic Response

Related documents